Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of EXOPULSE Mollii Suit on Fibromyalgia Syndrome in Patients With Fibromyalgia (EXOFIB 2): A Sham Controlled Randomized Double-Blind Trial

NCT06226376 is registered in ClinicalTrials.gov with Sheikh Shakhbout Medical City as lead sponsor.

NCT NCT06226376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06226376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of EXOPULSE Mollii Suit on Fibromyalgia Syndrome in Patients With Fibromyalgia (EXOFIB 2): A Sham Controlled Randomized Double-Blind Trial
Lead sponsor
Sheikh Shakhbout Medical City
Phase
Not applicable
Overall status
Completed
Start date
January 8, 2024
Completion date
May 24, 2025
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia, muscular diseases, nervous system diseases, neuromuscular diseases, rheumatic diseases